Annual report pursuant to Section 13 and 15(d)

Consolidated Statement of Changes in Shareholders' Equity

v3.20.1
Consolidated Statement of Changes in Shareholders' Equity - USD ($)
Series B Convertible Preferred Stock [Member]
Common Stock [Member]
Deferred Compensation [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Income/(Loss) [Member]
Total
Balance at Dec. 31, 2017 $ 1,755,000 $ 110,647,169 $ (3,469) $ (104,845,847) $ 7,552,853
Balance, shares at Dec. 31, 2017 1,755 251,227        
Net loss (10,849,034) (10,849,034)
Exercise of warrants for common stock $ 7,155,200 7,155,200
Exercise of warrants for common stock, shares 199,055        
Conversion of preferred stock to common stock $ (1,755,000) $ 1,755,000
Conversion of preferred stock to common stock, shares (1,755) 60,943        
Private offering of common stock, net of offering costs of $50,000   $ 1,950,000       1,950,000
Private offering of common stock, net of offering costs $50,000, shares   28,937        
Amortization of deferred compensation 3,469 3,469
Issuance of stock grants to officer $ 27,702 27,702
Issuance of stock grants to officer, shares 445        
Stock-based compensation - stock options $ 6,931 6,931
Stock-based compensation - restricted stock 12,545 12,545
Net unrealized gain loss on marketable securities (25,913) (25,913)
Balance at Dec. 31, 2018 $ 121,554,547 (115,694,881) (25,913) 5,833,753
Balance, shares at Dec. 31, 2018 540,607        
Net loss (3,888,249) (3,888,249)
Public offering - common stock, net of offering costs of $306,222 $ 2,147,778 2,147,778
Public offering - common stock, net of offering costs of $306,222, shares 613,500        
Public offering - prepaid equity forward contracts, net of offering costs of $688,005 $ 4,817,857 4,817,857
Issuance of stock grants to officer $ 27,367 27,367
Issuance of stock grants to officer, shares 1,563        
Issuance of common stock to vendor for services $ 10,802 10,802
Issuance of common stock to vendor for services, shares 1,667        
Exercise of prepaid equity forward contracts for common stock $ 58 58
Exercise of prepaid equity forward contracts for common stock, shares 581,500        
Stock-based compensation - restricted stock $ 362,005 362,005
Net unrealized gain loss on marketable securities 43,799 43,799
Balance at Dec. 31, 2019 $ 128,920,414 $ (119,583,130) $ 17,886 $ 9,355,170
Balance, shares at Dec. 31, 2019 1,738,837